Nichols Asset Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$255K Hold
3,555
0.5% 60
2016
Q3
$281K Hold
3,555
0.52% 59
2016
Q2
$297K Hold
3,555
0.6% 55
2016
Q1
$327K Sell
3,555
-1,989
-36% -$179K 0.07% 96
2015
Q4
$561K Sell
5,544
-375
-6% -$39K 0.12% 76
2015
Q3
$581K Hold
5,919
0.13% 74
2015
Q2
$693K Hold
5,919
0.12% 74
2015
Q1
$581K Hold
5,919
0.1% 83
2014
Q4
$558K Sell
5,919
-3,666
-38% -$379K 0.11% 85
2014
Q3
$1.02M Hold
9,585
0.21% 63
2014
Q2
$795K Sell
9,585
-1,985
-17% -$155K 0.16% 70
2014
Q1
$820K Hold
11,570
0.18% 72
2013
Q4
$869K Sell
11,570
-600
-5% -$41.8K 0.18% 69
2013
Q3
$765K Hold
12,170
0.21% 73
2013
Q2
$624K Buy
+12,170
New +$634K 0.19% 72

Other funds holding GILD

Nichols Asset Management's GILD Position: Q4 2016 in Review

Nichols Asset Management held its Gilead Sciences (GILD) position steady in Q4 2016 at 3,555 shares worth $255K. The position accounts for 0.5% of the portfolio, ranked #60.

Nichols Asset Management first reported a position in GILD in Q2 2013 and has held it in 15 quarters since. The position peaked at $1.02M in Q3 2014. 1,572 funds tracked by Wall St. Rank hold GILD as of Q4 2016.

  • Nichols Asset Management held 3,555 shares of Gilead Sciences worth $255K as of Q4 2016.
  • Nichols Asset Management left its Gilead Sciences share count unchanged in Q4 2016.
  • Gilead Sciences made up 0.5% of Nichols Asset Management's portfolio in Q4 2016, its #60 holding.
  • Nichols Asset Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 15 quarters since.
  • Nichols Asset Management's Gilead Sciences position peaked at $1.02M in Q3 2014.
  • 1,572 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2016.

Based on Nichols Asset Management's 13F filing for Q4 2016, filed 10 Feb 2017.